| Trade name |
MEDRx Co., Ltd |
| Establishment |
January, 2002 |
| Head office |
431-7 Nishiyama Higashikagawa-city, Kagawa, Japan
769-2712
TEL: +81-879-23-3071
FAX:+81-879-23-3072 |
| Tokyo office |
Shimazuru Build. 2F, 2-35-7 Hama-cho, Nihonbashi, Chuou-ku, Tokyo, Japan 103-0007
TEL：+81-3-3664-9630
FAX：+81-3-3664-9660 |
| Shirotori Labo |
1055 Matsubara Higashikagawa-city, Kagawa, JAPAN 769-2702
TEL：+81-879-26-3094
FAX：+81-879-26-0036 |
Subsidiary
MEDRx USA INC. |
2030 Main St.,Suite 1300
Irvine, CA USA 92614
TEL: +1-949-260-4788 |
| President & CEO |
Yonehiro Matsumura |
| Capital Fund |
5,101 million yen |
| Main business operation |
Pharmaceutical Drug Development based on the transdermal absorption system |
